Market revenue in 2024 | USD 873.0 million |
Market revenue in 2030 | USD 1,277.5 million |
Growth rate | 6.6% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Defibrillators |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 41.03% in 2024. Horizon Databook has segmented the UK cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
The cardiac rhythm management devices market in the UK has been growing in recent years. This can be attributed to the increasing prevalence of cardiac disorders, such as atrial fibrillation and congenital heart defects, which require the use of EP devices for diagnosis & treatment. As per the British Heart Foundation, in 2022, a total number of 174,884 people died due to CVD in the UK.
Furthermore, the UK government’s growing investment in healthcare research is expected to boost the market. For instance, in March 2022, the UK government announced an investment of USD 347 million to improve R&D, production of devices, diagnostics, and novel therapies.
Moreover, the UK government has another initiative named National Audit of Cardiac Rhythm Management (CRM). The National Audit of CRM conducts an annual review, gathering data on all implanted cardiac devices and patients undergoing interventional procedures for managing cardiac rhythm disorders in the UK. This audit report is published each year by the UK government.
Horizon Databook provides a detailed overview of country-level data and insights on the UK cardiac rhythm management devices market, including forecasts for subscribers. This country databook contains high-level insights into UK cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account